Heparin Science

FDA authorizes Bioiberica�s customers to commercialize their heparin

The authorization process started at the end of 2008, when Bioib�rica sent their DMF (Drug Master File) to the North American organization. In March 2009, Bioib�rica�s installations in Palafolls (Gerona), and Ol�rdola (Barcelona) were examined by ...

New Heparin Production Plants

Investments in new production facilities have consolidated Bioiberica as the world leader in Heparin production.

This year, the production facilities in Poland have been expanded and new plants have been opened in the United States ...

Bioiberica created a new division: Heparin Science

A new Department has been created in Bioiberica S.A. in September 2007 under the name: HEPARIN SCIENCE.

HEPARIN SCIENCE must consolidate Bioib�rica�s leading position in the Heparin market, the reason for its creation in 1975.

Bioiberica obtains the International SA8000 Certification of Corporate Social Responsability

Last september Bioib�rica, S.A. obtained the international SA8000 Certification of Corporate Social Responsibility. With this certificate Bioib�rica has proved its corporate values, based on achieving results through people and their commitment to ...